These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36271455)

  • 1. Patient journey and resources mapping to implement a praziquantel mass drug administration program for children aged 5 years and below in resource-limited settings.
    Ncube MV; Kabuyaya M; Chimbari MJ
    Syst Rev; 2022 Oct; 11(1):227. PubMed ID: 36271455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Praziquantel-related visual disorders among recipients in mass drug administration campaigns in schistosomiasis endemic settings: Systematic review and meta-analysis protocol.
    Danso-Appiah A; Owiredu D; Akuffo KO
    PLoS One; 2024; 19(5):e0300384. PubMed ID: 38758736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-seeking behaviour regarding schistosomiasis treatment in the absence of a mass drug administration (MDA) program: the case of endemic communities along Lake Albert in Western Uganda.
    Anyolitho MK; Nyakato VN; Huyse T; Poels K; Masquillier C
    BMC Public Health; 2023 Jun; 23(1):1072. PubMed ID: 37277773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) - single versus multiple praziquantel treatments in school-aged children in Côte d'Ivoire: a study protocol for an open-label, randomised controlled trial.
    Hoekstra PT; Casacuberta Partal M; Amoah AS; van Lieshout L; Corstjens PLAM; Tsonaka S; Assaré RK; Silué KD; Meité A; N'Goran EK; N'Gbesso YK; Roestenberg M; Knopp S; Utzinger J; Coulibaly JT; van Dam GJ
    BMC Infect Dis; 2018 Dec; 18(1):662. PubMed ID: 30547750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paediatric schistosomiasis: last mile preparations for deploying paediatric praziquantel.
    Mutapi F; Garba A; Woolhouse M; Kazyoba P
    Trends Parasitol; 2024 Aug; 40(8):687-695. PubMed ID: 39033047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can direct smear results that are routinely collected at health centre level be used for monitoring the impact of mass drug administration with praziquantel on schistosomiasis in Burundi? A preliminary assessment.
    Bizimana P; Polman K; Ortu G; Krit M; Nsabiyumva F; Nkeshimana A; Bijabuka U; Nibakire M; Van Geertruyden JP
    Parasit Vectors; 2020 Apr; 13(1):206. PubMed ID: 32317007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of pediatric schistosomiasis in hard-to-reach areas and populations: A scoping review protocol.
    Isaiah PM; Palmeirim MS; Steinmann P
    F1000Res; 2022; 11():1203. PubMed ID: 36761831
    [No Abstract]   [Full Text] [Related]  

  • 8. Paediatric and maternal schistosomiasis: shifting the paradigms.
    Bustinduy AL; Stothard JR; Friedman JF
    Br Med Bull; 2017 Sep; 123(1):115-125. PubMed ID: 28910994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative palatability of orally disintegrating tablets (ODTs) of Praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children: A randomized, single-blind, crossover study.
    Mahende MK; Huber E; Kourany-Lefoll E; Ali A; Hayward B; Bezuidenhout D; Bagchus W; Kabanywanyi AM
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0007370. PubMed ID: 34106922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children.
    Sousa-Figueiredo JC; Betson M; Atuhaire A; Arinaitwe M; Navaratnam AM; Kabatereine NB; Bickle Q; Stothard JR
    PLoS Negl Trop Dis; 2012; 6(10):e1864. PubMed ID: 23094120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose or multi-day praziquantel for imported schistosomiasis? A systematic review.
    Cucchetto G; Buonfrate D; Marchese V; Rodari P; Ferrari A; Zanotti P; Bottieau E; Silva R; Bisoffi Z; Gobbi F
    J Travel Med; 2019 Oct; 26(7):. PubMed ID: 31309979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schistosomiasis control in Senegal: results from community data analysis for optimizing preventive chemotherapy intervention with praziquantel.
    Diop B; Sylla K; Kane NM; Boh OK; Guèye B; Ba M; Talla I; Mané M; Monteil R; Kinvi B; Zoure HGM; Ortega JC; Mwinzi P; Sacko M; Faye B
    Infect Dis Poverty; 2023 Nov; 12(1):106. PubMed ID: 38008772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential impact of mass and targeted praziquantel delivery on schistosomiasis control in school-aged children: A systematic review and meta-analysis.
    Cribb DM; Clarke NE; Doi SAR; Vaz Nery S
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007808. PubMed ID: 31603895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum.
    Bustinduy AL; Kolamunnage-Dona R; Mirochnick MH; Capparelli EV; Tallo V; Acosta LP; Olveda RM; Friedman JF; Hope WW
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated community-directed treatment for the control of onchocerciasis, schistosomiasis and intestinal helminths infections in Uganda: advantages and disadvantages.
    Ndyomugyenyi R; Kabatereine N
    Trop Med Int Health; 2003 Nov; 8(11):997-1004. PubMed ID: 14629766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining treatment needs at different spatial scales using geostatistical model-based risk estimates of schistosomiasis.
    Schur N; Vounatsou P; Utzinger J
    PLoS Negl Trop Dis; 2012; 6(9):e1773. PubMed ID: 23029570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putting the treatment of paediatric schistosomiasis into context.
    Mduluza T; Mutapi F
    Infect Dis Poverty; 2017 Apr; 6(1):85. PubMed ID: 28388940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Schistosoma mansoni infection and the therapeutic efficacy of praziquantel among school children in Manna District, Jimma Zone, southwest Ethiopia.
    Bajiro M; Dana D; Ayana M; Emana D; Mekonnen Z; Zawdie B; Garbi A; Kure A; Zeynudin A
    Parasit Vectors; 2016 Oct; 9(1):560. PubMed ID: 27772528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The praziquantel in preschoolers (PIP) trial: study protocol for a phase II PK/PD-driven randomised controlled trial of praziquantel in children under 4 years of age.
    Webb EL; Edielu A; Wu HW; Kabatereine NB; Tukahebwa EM; Mubangizi A; Adriko M; Elliott AM; Hope WW; Mawa PA; Friedman JF; Bustinduy AL
    Trials; 2021 Sep; 22(1):601. PubMed ID: 34488846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety.
    Navaratnam AM; Sousa-Figueiredo JC; Stothard JR; Kabatereine NB; Fenwick A; Mutumba-Nakalembe MJ
    Trans R Soc Trop Med Hyg; 2012 Jul; 106(7):400-7. PubMed ID: 22657533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.